PMID: 16629384Apr 25, 2006Paper

RNAi as a treatment for HIV-1 infection

BioTechniques
John J Rossi

Abstract

Human immunodeficiency virus type 1 (HIV-1) was the first primate virus shown to be inhibited by RNA interference (RNAi). Early studies used both synthetic and promoter expressed small interfering RNAs (siRNAs) or expressed short hairpin RNAs (shRNAs) to demonstrate that this virus was susceptible to RNAi. In addition to targeting the virus itself RNAi-mediated down-regulation of cellular targets that encode receptors required for viral entry also proved to be effective. The power of RNAi as an anti-HIV agent has propelled development of RNAi-based gene therapy approaches for the treatment of HIV infection in humans. Nevertheless, extensive in vitro experimentation has revealed potential problems of viral escape mutants and other toxicities caused by the si/shRNAs. This review covers the progress and problems in the development of RNAi for the treatment of HIV infection. Potential modalities for clinical application of RNAi in the treatment of HIV-1 infection are also described.

References

Dec 12, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·B Dropulic
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Patrick J PaddisonGregory J Hannon
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
May 1, 2002·Nature Biotechnology·Cynthia P PaulDavid R Engelke
Jun 4, 2002·Nature Medicine·Carl D NovinaPhillip A Sharp
Jun 28, 2002·Nature·Jean-Marc JacqueMario Stevenson
Dec 5, 2002·Trends in Immunology·Miguel Angel MartínezJosé A Esté
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Jun 11, 2003·Nature Genetics·Alan J BridgeRichard Iggo
Aug 28, 2003·Nature Cell Biology·Carol A SledzBryan R G Williams
Oct 15, 2003·Journal of Virology·Daniel BodenBharat Ramratnam
Jan 31, 2004·Annals of the New York Academy of Sciences·Alessandro MichienziJohn J Rossi
Feb 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sunita GuptaVivek Mittal
Feb 14, 2004·Journal of Virology·Atze T DasBen Berkhout
Sep 17, 2004·Nature·Gregory J Hannon, John J Rossi
Nov 24, 2004·FEBS Letters·Xiaoyu LinYu Shen
Nov 30, 2004·Nature Biotechnology·Hoshang J UnwallaJohn J Rossi
Jan 13, 2005·Methods in Enzymology·Jenn-Yah YuDavid L Turner
Feb 3, 2005·Nucleic Acids Research·Ellen M WesterhoutBen Berkhout
Mar 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dong XuR L Juliano
Mar 22, 2005·Nature Biotechnology·Adam D JudgeIan MacLachlan
May 17, 2005·Immunity·Yamina BennasserKuan-Teh Jeang
Jul 2, 2005·Oligonucleotides·Juhana E HeinonenC I Edvard Smith
Aug 19, 2005·Nature·Raffaele De Francesco, Giovanni Migliaccio
Sep 24, 2005·Gene Therapy·J N Leonard, D V Schaffer
Dec 16, 2005·The AAPS Journal·Madhavan P N NairDon Sykes
Dec 28, 2005·Journal of Virology·Rosario SabariegosMiguel Angel Martínez
Dec 31, 2005·Retrovirology·Man Lung YeungKuan-Teh Jeang
Jan 6, 2006·Annals of the New York Academy of Sciences·Zhi-Ming ZhengMingfang Tao

❮ Previous
Next ❯

Citations

Aug 12, 2009·Journal of the American Chemical Society·Julian M GlückBernd W Koenig
Dec 10, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sang-Soo KimPremlata Shankar
Sep 29, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jiehua ZhouJohn J Rossi
Nov 21, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jiehua ZhouJohn J Rossi
Jan 21, 2011·Science Translational Medicine·Charles Preston NeffRamesh Akkina
Dec 18, 2013·Journal of Translational Medicine·Abid QureshiManoj Kumar
Jul 3, 2007·PLoS Genetics·Matthew WoodGraham McClorey
Oct 25, 2011·PloS One·Atul TyagiManoj Kumar
Mar 21, 2008·Expert Opinion on Biological Therapy·Sunit K Singh
Jan 22, 2010·Expert Opinion on Biological Therapy·Sandesh SubramanyaPremlata Shankar
Feb 25, 2009·Expert Opinion on Biological Therapy·Ben Berkhout, Olivier ter Brake
May 31, 2014·Nucleic Acids Research·Michael HannusGunter Meister
Nov 21, 2007·Journal of Liposome Research·Camilla FogedSven Frokjaer
Jul 16, 2008·Biochemical and Biophysical Research Communications·Jiyeon SonSang-Kyung Lee
Oct 29, 2015·Physical Chemistry Chemical Physics : PCCP·Sathish Kumar MudedlaVenkatesan Subramanian
Apr 12, 2007·Nucleic Acids Research·Lisa J SchererJohn J Rossi
Apr 16, 2018·Reviews in Medical Virology·Abid QureshiAbdul Ghani Ahangar
Nov 16, 2007·Orvosi hetilap·Gyöngyi MunkácsyBalázs Gyorffy
Oct 3, 2009·Annals of the New York Academy of Sciences·Ben Berkhout
Dec 11, 2007·Nature Biotechnology·Joost HaasnootBen Berkhout
Feb 17, 2007·Nature Reviews. Genetics·Daniel H Kim, John J Rossi
Mar 26, 2009·Current Protocols in Nucleic Acid Chemistry·Daniel H Kim, John J Rossi
Aug 1, 2007·Personalized Medicine·Kevin V Morris
Jul 15, 2017·AIDS Research and Therapy·Alexander KwartengGodwin Kwakye-Nuako
Nov 21, 2020·BMC Veterinary Research·Otávio Valério de CarvalhoAbelardo Silva-Júnior

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.